REPAGLINIDE Rivopharm cpr 0.5 mg 90 pce
7680612340164
CH-61234
A10BX02
07.06.2.
Active substances:
Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 6123401
- CPT
- -
- Packaging group
- 90
- Unit
- Tablette(n)
- Composition
- repaglinidum 0.5 mg, polacrilinum kalicum, megluminum, cellulosum microcristallinum, maydis amylum, povidonum K 90, glycerolum, poloxamerum, calcii hydrogenophosphas, magnesii stearas, pro compresso.
Articles (1)
Repaglinide Rivopharm 0.5 mg, compresse
Tupfer
90
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
repaglinidum
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
polacrilinum kalicum
|
- | Substance | HNIDK |
|
megluminum
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
maydis amylum
|
- | Substance | HNIDK |
|
povidonum K 90
|
- | Substance | HNIDK |
|
glycerolum
|
- | Substance | HNIDK |
|
poloxamerum
|
- | Substance | HNIDK |
|
calcii hydrogenophosphas
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 25.55
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/05/2023
Authorization holder
Rivopharm SA
6928 Manno
Authorization information
- Swissmedic authorization number
- 61234
- Drug name
- Repaglinide Rivopharm, compresse
- Galenic form
- TAB
- ATC Code
- A10BX02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 24/05/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- REPAGLINIDE Rivopharm cpr 0.5 mg 90 pce
- Description (DE)
- REPAGLINIDE Rivopharm Tabl 0.5 mg 90 Stk
- Market launch
- 24/05/2011
- Narcotic (BTM)
- No